Cimaterol Antikörper
Kurzübersicht für Cimaterol Antikörper (ABIN1000420)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Cimaterol
-
Spezifität
- Compound % Cross-Reactivity Clenbuterol 100 Mabuterol 114 Brombuterol 96 Methyl-Clenbuterol 53 Mapenterol 49 Salbutamol 3.8 Terbutaline 1.6 Cimaterol < 1.0 Pirbuterol 0.9 Ractopamine < 0.2 Feneterol < 0.3
-
Aufreinigung
- Salt fractionation.
-
Immunogen
- Cimaterol-BSA
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Application_Dilutions: 1/500
Tested_Applications: The antibody is suitable for the development of immunoassays or immunoaffinity purification columns.
-
Kommentare
-
10 ng/mL Cimaterol produces 31 % inhibition in a competitive ELISA employing Cimaterol polyclonal antibody.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride. pH 7.4, 0.09 % Sodium Azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Can be stored for up to 3 months at +2°C - +8°C. For long term storage, aliquot and store at ≤-20 °C. Avoid repeated freeze/thaw cycles. Product should be protected from light exposure.
-
-
- Cimaterol
-
Substanzklasse
- Chemical
-
Hintergrund
- Beta-agonists are compounds having a stimulatory effect on beta-adrenergic receptors and are used in human and veterinary medicine as bronchodilatory agents.
Target
-